Access to patient-level data from GlaxoSmithKline clinical trials.

dc.contributor.author	Nisen, Perry
dc.contributor.author	Rockhold, Frank
dc.coverage.spatial	United States
dc.date.accessioned	2015-12-03T17:29:52Z
dc.date.issued	2013-08-01
dc.identifier	https://www.ncbi.nlm.nih.gov/pubmed/23902490
dc.identifier.eissn	1533-4406
dc.identifier.uri	https://hdl.handle.net/10161/11001
dc.language	eng
dc.publisher	Massachusetts Medical Society
dc.relation.ispartof	N Engl J Med
dc.relation.isversionof	10.1056/NEJMsr1302541
dc.subject	Access to Information
dc.subject	Clinical Trials as Topic
dc.subject	Confidentiality
dc.subject	Drug Evaluation
dc.subject	Drug Industry
dc.subject	Humans
dc.subject	Information Dissemination
dc.subject	Internet
dc.title	Access to patient-level data from GlaxoSmithKline clinical trials.
dc.type	Journal article
duke.contributor.orcid	Rockhold, Frank\|0000-0003-3732-4765
pubs.author-url	https://www.ncbi.nlm.nih.gov/pubmed/23902490
pubs.begin-page	475
pubs.end-page	478
pubs.issue	5
pubs.organisational-group	Basic Science Departments
pubs.organisational-group	Biostatistics & Bioinformatics
pubs.organisational-group	Duke
pubs.organisational-group	Duke Clinical Research Institute
pubs.organisational-group	Institutes and Centers
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	369

Files

Now showing 1 - 1 of 1